2024年3月15日 — Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their ...
2024年4月2日 — In a prespecified analysis, the Freenome blood test for CRC screening demonstrated 79.2% sensitivity in detecting colorectal cancer (Stage I: ...
2024年4月25日 — Freenome, a developer of blood tests for early cancer detection, said it is eliminating just over 100 jobs, or about 20% of its staff, in a ...
Freenome's mission is to detect cancer in its earliest, most treatable stages and make screening easy and accessible for everyone. Foundational to Freenome's ...